0001179110-21-000881.txt : 20210127
0001179110-21-000881.hdr.sgml : 20210127
20210127164409
ACCESSION NUMBER: 0001179110-21-000881
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210125
FILED AS OF DATE: 20210127
DATE AS OF CHANGE: 20210127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kessler Jon
CENTRAL INDEX KEY: 0001615062
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36568
FILM NUMBER: 21560472
MAIL ADDRESS:
STREET 1: 15 W. SCENIC POINTE DR., STE. 100
CITY: DRAPER
STATE: UT
ZIP: 84020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HEALTHEQUITY, INC.
CENTRAL INDEX KEY: 0001428336
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0131
BUSINESS ADDRESS:
STREET 1: 15 WEST SCENIC POINTE DRIVE
STREET 2: SUITE 100
CITY: DRAPER
STATE: UT
ZIP: 84020
BUSINESS PHONE: 801-727-1000
MAIL ADDRESS:
STREET 1: 15 WEST SCENIC POINTE DRIVE
STREET 2: SUITE 100
CITY: DRAPER
STATE: UT
ZIP: 84020
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHEQUITY INC
DATE OF NAME CHANGE: 20080227
4
1
edgar.xml
FORM 4 -
X0306
4
2021-01-25
0
0001428336
HEALTHEQUITY, INC.
HQY
0001615062
Kessler Jon
15 WEST SCENIC POINTE DRIVE, SUITE 100
DRAPER
UT
84020
1
1
0
0
President and CEO
Common Stock
2021-01-25
4
S
0
54858
84.4595
D
350857
D
Common Stock
2021-01-25
4
S
0
56141
85.0581
D
294716
D
Common Stock
2021-01-25
4
S
0
21448
86.1154
D
273268
D
Common Stock
2021-01-25
4
S
0
17553
87.1275
D
255715
D
Stock Option (right to buy)
41.28
2027-03-27
Common Stock
17410
34820
I
by GKF, LLC
Stock Option (right to buy)
61.72
2028-03-27
Common Stock
11965
23930
I
by GKF, LLC
Stock Option (right to buy)
73.61
2029-03-26
Common Stock
12782
12782
I
by GKF, LLC
Stock Option (right to buy)
14.00
2024-07-30
Common Stock
160000
160000
I
by GKF, LLC
Stock Option (right to buy)
41.28
2027-03-27
Common Stock
34819
17409
D
Stock Option (right to buy)
61.72
2028-03-27
Common Stock
35894
23929
D
Stock Option (right to buy)
73.61
2029-03-26
Common Stock
51125
38343
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.75 to $84.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4), and (5) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.75 to $85.74, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.75 to $86.74, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.76 to $87.58, inclusive.
The option is immediately exercisable.
The option will become exercisable as to 17,409 shares on March 27, 2021.
The option will become exercisable as to 11,965 shares on March 27, 2021 and 11,964 shares on March 27, 2022.
The option will become exercisable in annual installments of 12,781 shares on each of March 26, 2021, 2022 and 2023.
/s/ Jon Kessler
2021-01-26